Depression, anxiety, and psychotropic medication use and fecundability

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 4, 2016, Pages 453.e1-453.e8

  Nillni, Yael I ^a,b   Wesselink, Amelia K ^c   Gradus, Jaimie L ^a,b,c   Hatch, Elizabeth E ^c   Rothman, Kenneth J ^c,e   Mikkelsen, Ellen M ^f   Wise, Lauren A ^c,d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY   (United States)

^e RTI HEALTH SOLUTIONS   (United States)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

anxiety; depression; fecundability; psychotropic medication

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ANXIETY; BODY MASS; COHORT ANALYSIS; CONCEPTION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FERTILITY; FOLLOW UP; HOUSEHOLD INCOME; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SMOKING; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; PUERPERAL DEPRESSION; SELF REPORT; YOUNG ADULT; COMPLICATION; DEPRESSION; DRUG EFFECTS; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ADULT; ANXIETY; DEPRESSION; FEMALE; FERTILITY; HUMANS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84971601525     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.04.022     Document Type: Conference Paper

References (26)

1. 1 Thoma, M.E., McLain, A.C., Louis, J.F., et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril 99 (2013), 1324–1331.
2. 2 Seeman, M.V., Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154 (1997), 1641–1647.
3. 3 Weissman, M.M., Olfson, M., Depression in women: implications for health care research. Science 269 (1995), 799–801.
4. 4 Vreeburg, S.A., Hoogendijk, W.J., van Pelt, J., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66 (2009), 617–626.
5. 5 Ferin, M., Stress and the reproductive cycle. J Clin Endocrinol Metab 84 (1999), 1768–1774.
6. 6 Margolese, H.C., Assalian, P., Sexual side effects of antidepressants: a review. J Sex Marital Ther 22 (1996), 209–217.
7. 7 Timby, E., Hedström, H., Bäckström, T., Sundström-Poromaa, I., Nyberg, S., Bixo, M., Allopregnanolone, a GABAA receptor agonist, decreases gonadotropin levels in women. A preliminary study. Gynecol Endocrinol 27 (2011), 1087–1093.
8. 8 Lapane, K.L., Zierler, S., Lasater, T.M., Stein, M., Barbour, M.M., Hume, A.L., Is a history of depressive symptoms associated with an increased risk of infertility in women?. Psychosom Med 57 (1995), 509–513.
9. 9 Williams, K.E., Marsh, W.K., Rasgon, N.L., Mood disorders and fertility in women: a critical review of the literature and implications for future research. Hum Reprod Update 13 (2007), 607–616.
10. 10 Lynch, C.D., Sundaram, R., Buck Louis, G.M., Lum, K.J., Pyper, C., Are increased levels of self-reported psychosocial stress, anxiety, and depression associated with fecundity?. Fertil Steril 98 (2012), 453–458.
11. 11 Gorman, J.M., Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4 (1996-1997), 160–168.
12. 12 Grodstein, F., Goldman, M.B., Ryan, L., Cramer, D.W., Self-reported use of pharmaceuticals and primary ovulatory infertility. Epidemiology 4 (1993), 151–156.
13. 13 Casilla-Lennon, M., Chantala, K., Meltzer-Brody, S., Steiner, A., The effect of antidepressants on fertility. Fertil Steril, 2016.
14. 14 Wise, L.A., Rothman, K.J., Mikkelsen, E.M., et al. Design and conduct of an Internet-based preconception cohort study in North America: pregnancy study online. Paediatr Perinat Epidemiol 29 (2015), 360–371.
15. 15 Bech, P., Quality of life instruments in depression. Eur Psychiatry 12 (1997), 194–198.
16. 16 Bech, P., Wermuth, L., Applicability and validity of the Major Depression Inventory in patients with Parkinson's disease. Nord J Psychiatr 52 (1998), 305–310.
17. 17 Bech, P., Rasmussen, N.A., Olsen, L.R., Noerholm, V., Abildgaard, W., The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 66 (2001), 159–164.
18. 18 Ainsworth, B.E., Haskell, W.L., Herrmann, S.D., et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43 (2011), 1575–1581.
19. 19 Weinberg, C.R., Wilcox, A.J., Baird, D.D., Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 129 (1989), 1072–1078.
20. 20 Weinberg, C.R., Wilcox, A.J., Reproductive epidemiology. Rothman, K.J., Greenland, S., (eds.) Modern epidemiology, 1998, Lippincott Raven, Philadelphia (PA).
21. 21 Therneau, T.M., Grambsch, P.M., Modeling survival data: extending the Cox model. 2000, Springer-Verlag, New York.
22. 22 SAS Institute. SAS/Stat 9.3 user's guide. 2008, SAS Institute, Cary (NC).
23. 23 Zigmond, A.S., Snaith, R.P., The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67 (1983), 361–370.
24. 24 Rothman, K.J., Six persistent research misconceptions. J Gen Intern Med 29 (2014), 1060–1064.
25. 25 Ziliak, S.T., McCloskey, D.N., The cult of statistical significance. 2008, University of Michigan Press, Ann Arbor (MI), 27.
26. 26 Kessler, R.C., Berglund, P., Demler, O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003), 3095–3105.